Sava
Builds a minimally invasive wearable biosensor that tracks glucose, lactate and other biomarkers in real time.
sava.health ↗Why it's here
Raised a €16.3M Series A in July 2025 from investors including Balderton Capital, Norrsken VC and JamJar Investments.
source: vestbee.com- Focus
- Wearable Biosensors
- Founded
- 2016
- Latest round
- Series A, €16.3M, Jul 2025
- Staff (Companies House accounts)
- 40, average over the period to 30 Mar 2025source: find-and-update.company-information.service.gov.uk
- London office
- 117 Charterhouse Street, Islington EC1M 6AAsource: sava.health
- London presence
- HQsource: sava.health
- Investors
- Athletico Ventures, Balderton Capital, Exceptional Ventures, Italian Founders Fund, JamJar Investments, Norrsken VC, Pentland Ventures, Solo Investments, Truesource: vestbee.com
- Nearest station
- Barbican, 185 m
- Visas
- Licensed visa sponsor, listed as SAVA Technologies Ltdsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix